{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T06:57:55Z","timestamp":1780901875580,"version":"3.54.1"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Ophthalmol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To determine the incidence of retinal detachment (RD) following acute retinal necrosis (ARN) and to evaluate demographic and treatment-related associations using a large, multi-institutional database. Design: Retrospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Setting: TriNetX Research Network. Study population: Patients diagnosed with ARN between January 1, 2014, and January 1, 2024. Procedures: ARN and RD were identified using ICD and CPT codes. Chi-square tests, risk ratio analyses, and logistic regression models were used to evaluate demographic and treatment-related associations of RD. Main outcome measures: Incidence and associations for RD at 3, 6, and 12 months post-diagnosis of ARN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 1,785 patients with ARN, the overall incidence of RD was 12.49% (n=223), with 135 cases (60.5%) occurring within the first 3 months of diagnosis and 88 cases (39.5%) occurring thereafter. Although aggressive combination therapy consisting of systemic corticosteroids, oral valacyclovir, and\/or intravitreal foscarnet was primarily used in severe cases, RD still occurred frequently. No significant differences were observed in RD incidence based on age, sex, diabetes status, or immunosuppression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this large EHR-based cohort, RD following ARN occurred most commonly within the first 3 months after diagnosis. Treatment exposures (corticosteroids, valacyclovir, intravitreal foscarnet) should be interpreted strictly as proxies of disease severity, not independent risk factors for RD. These findings underscore the importance of close ophthalmic monitoring during the first 3 months after ARN diagnosis, when the risk of RD is highest.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fopht.2026.1829400","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T06:01:07Z","timestamp":1780898467000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence and clinical characterization of retinal detachment in acute retinal necrosis: a global federated database analysis"],"prefix":"10.3389","volume":"6","author":[{"given":"Donovin","family":"Thompson","sequence":"first","affiliation":[{"name":"Drexel University College of Medicine","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidra","family":"Zafar","sequence":"additional","affiliation":[{"name":"Wills Eye Hospital, Sidney Kimmel School of Medicine","place":["Philadelphia, PA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Berkenstock","sequence":"additional","affiliation":[{"name":"Division of Ocular Immunology, Wilmer Eye Institute, Johns Hopkins School of Medicine","place":["Baltimore, MD, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12020386","article-title":"Acute retinal necrosis: Signs, treatment, complications and outcome","volume":"12","author":"Mayer","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2011.338","article-title":"Acute retinal necrosis in the United Kingdom: Results of a prospective surveillance study","volume":"26","author":"Cochrane","year":"2012","journal-title":"Eye (Lond)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40942-022-00417-w","article-title":"Acute retinal necrosis. Management and visual outcomes: a case series","volume":"8","author":"Mojarrad","year":"2022","journal-title":"Int J Retina Vitreous"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002971","article-title":"Retinal detachment after acute retinal necrosis and the efficacies of different interventions: a systematic review and meta-analysis","volume":"41","author":"Zhao","year":"2021","journal-title":"Retina"},{"key":"B5","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12886-024-03533-3","article-title":"Risk factors and prognostic factors associated with retinal detachment and visual outcomes in acute retinal necrosis","volume":"24","author":"Li","year":"2024","journal-title":"BMC Ophthalmol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002971","article-title":"Retinal detachment after acute retinal necrosis and the efficacies of different interventions","volume":"41","author":"Zhao","year":"2020","journal-title":"Retina"},{"key":"B7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12886-020-01514-w","article-title":"Acute retinal necrosis following dexamethasone intravitreal implant (Ozurdex\u00ae) administration in an immunocompetent adult with a history of HSV encephalitis: a case report","volume":"20","author":"Zhang","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2018.02.001","article-title":"Comparing treatment of acute retinal necrosis with either oral valacyclovir or intravenous acyclovir","volume":"188","author":"Baltinas","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000017001","article-title":"Fulminant bilateral acute retinal necrosis complicated with secondary herpes simplex type-1 viral encephalitis","volume":"98","author":"Ye","year":"2019","journal-title":"Medicine"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2025.2456642","article-title":"Multicenter analysis of acute retinal necrosis: Clinical characteristics, viral pathogens, and diagnostic predictive factors","volume":"33","author":"Soitong","year":"2025","journal-title":"Ocul Immunol Inflammation"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2022.01.016","article-title":"Risk factors for retinal detachment in acute retinal necrosis","volume":"6","author":"Bavinger","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"B12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.survophthal.2023.09.004","article-title":"Antiviral treatment for acute retinal necrosis: A systematic review and meta-analysis","volume":"69","author":"Putera","year":"2024","journal-title":"Surv Ophthalmol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2024.07.020","article-title":"Treatment regimen and outcomes in acute retinal necrosis: An IRIS\u00ae Registry study","volume":"131","author":"Lains","year":"2024","journal-title":"Ophthalmology"},{"key":"B14","article-title":"Acute retinal necrosis","volume-title":"StatPearls [Internet]","author":"Tripathy","year":"2026"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-021-05166-4","article-title":"Association of retinal detachment with age 50 years or younger at onset in patients with acute retinal necrosis","volume":"259","author":"Urzua","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2017.06.014","article-title":"Poor prognosis of elderly individuals >80 years of age with acute retinal necrosis","volume":"7","author":"Yanai","year":"2017","journal-title":"Am J Ophthalmol Case Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00397-017-0997-0","article-title":"Rheological behaviour of vitreous humour","volume":"56","author":"Silva","year":"2017","journal-title":"Rheol Acta"},{"key":"B18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12348-022-00303-4","article-title":"Socioeconomic disadvantage and impact on visual outcomes in patients with viral retinitis and retinal detachment","volume":"12","author":"Zhou","year":"2022","journal-title":"J\u00a0Ophthalmic Inflammation Infect"},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-90495-5_7-1","article-title":"Acute retinal necrosis (ARN)","volume-title":"Albert and jakobiec's principles and practice of ophthalmology","author":"Davis","year":"2020"},{"key":"B20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.21037\/AES-2019-DMU-09","article-title":"Advances in the diagnosis and management of acute retinal necrosis","volume":"5","author":"Anthony","year":"2020","journal-title":"Ann Eye Sci"}],"container-title":["Frontiers in Ophthalmology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fopht.2026.1829400\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T06:01:08Z","timestamp":1780898468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fopht.2026.1829400\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":20,"alternative-id":["10.3389\/fopht.2026.1829400"],"URL":"https:\/\/doi.org\/10.3389\/fopht.2026.1829400","relation":{},"ISSN":["2674-0826"],"issn-type":[{"value":"2674-0826","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"article-number":"1829400"}}